The U.S. Food and Drug Administration approved generic versions of the best-selling blood thining drug Plavix on Thursday. More
SNY
Recent Articles
Pfizer is Still a Pharmaceutical-Giant Buy
Despite a slowdown in sales as Lipitor becomes a generic drug, pharma giant Pfizer is still a very good buy, and a great play for your portfolio. More
Sanofi, Michael J. Fox Foundation to Test Parkinson’s Drug
The Michael J. Fox Foundation will team up with French drugmaker Sanofi to test an experimental treatment for Parkinson's disease. More
Survey: Americans Prefer Samsung Over Sony
A consumer survey finds that Samsung has eclipsed Sony's popularity among American HDTV buyers. More
Dividend News: Apple, Raytheon and WPC
Over the past week, Apple announced that it will pay dividends for the first time since 1996, and two solid payout performers announced dividend increases. More
9 Pharma Buys for a Healthy Portfolio
Their dividends are attractive, and some drugmakers have made great progress in refilling their pipelines. More
